MedPath

Clinical and Laboratory Characteristics of Polycythemia Vera

Completed
Conditions
Polycythemia Vera
Registration Number
NCT06134102
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

The study is observational, longitudinal, retrospective and prospective, on patients with PV. Patients with PV diagnosed from 2000 to 2023 according to WHO2017 criteria will be considered. The main purpose of the study is to determine the impact of clinical and laboratory characteristics of Polycythemia Vera on patients' prognosis, understood as long-term survival

Detailed Description

The structured collection of data necessary for the evaluation of the objectives will take place through the creation of a specific electronic archive with an expected duration of 7 years, possibly extendable. The electronic archive may be used to review case histories and to obtain or confirm new scientific evidence on Polycythemia Vera. Patients will be followed and treated within the care pathway provided by normal clinical practice.

The following elements will be considered in each patient: age, recent and remote pathological history, characteristics of PV onset, histological, cytogenetic and molecular investigations of diagnostic definition, medical therapies performed, type of response to the therapies performed, complications of these therapies and pathology. All useful data will be collected exclusively through consultation of outpatient medical records.

The planned enrollment period is 60 months (January 2019-December 2023). The observation period of enrolled patients is at least 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1150
Inclusion Criteria
  • Patients diagnosed with PV according to WHO 2017 criteria,
  • Obtaining informed consent for data collection and processing
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Long-term survival6 years

To determine the impact of clinical and laboratory characteristics of Polycythemia Vera (PV) on patients' prognosis, in terms of lon term survival

Secondary Outcome Measures
NameTimeMethod
Therapies Efficacy6 years

To assess the effects of therapies

Evolution to acute leukemias6 years

To assess the incidence of acute leukaemias

Thrombosis6 years

To assess the incidence of thrombotic events on PV patients

Haemorrhages6 years

To assess the incidence of haemorrhagic events on PV patients

Therapies Toxicity6 years

To assess the toxicity of therapies

Development of second neoplasms6 years

To assess the incidence of second malignancies

Therapies6 years

To assess the use of high-cost therapies

Trial Locations

Locations (22)

Policlinico di Modena

🇮🇹

Modena, Emilia-Romagna, Italy

AUSL di Piacenza - Palazzine Medicine Specialistiche

🇮🇹

Piacenza, Emilia-Romagna, Italy

Grande Ospedale Metropolitano "Bianchi Melacrino Morelli"

🇮🇹

Reggio Calabria, Calabria, Italy

Ospedale Infermi Rimini

🇮🇹

Rimini, Emilia-Romagna, Italy

IRCCS Azienda Ospedaliera Universitaria "San Martino" - IST

🇮🇹

Genova, Liguria, Italy

IRCCS Policlinico Sant'Orsola

🇮🇹

Bologna, Emilia Romagna, Italy

Dipartimento Oncoematologico - AUSL della Romagna

🇮🇹

Ravenna, Emilia-Romagna, Italy

Ospedale Casa Sollievo della Sofferenza

🇮🇹

San Giovanni Rotondo, Puglia, Italy

IRCCS per l'oncologia -Ospedale Policlinico "San Martino"

🇮🇹

Genova, Liguria, Italy

Università degli studi di Ferrara - Nuovo Polo Ospedaliero di Cona - A.O.U. Arcispedale S. Anna

🇮🇹

Ferrara, Emilia-Romagna, Italy

A.O.U. Policlinico Umberto I - Università degli Studi di Roma "La Sapienza"

🇮🇹

Roma, Lazio, Italy

Arcispedale Santa Maria Nuova - IRCCS

🇮🇹

Reggio Emilia, Emilia-Romagna, Italy

Ospedale San Gerardo

🇮🇹

Monza, Lombardia, Italy

A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore

🇮🇹

Pesaro, Marche, Italy

A.O.U. Integrata di Udine

🇮🇹

Udine, Friuli-Venezia Giulia, Italy

ASST Spedali Civili di Brescia

🇮🇹

Brescia, Lombardia, Italy

Ospedale "A. Businco" - Dipartimento Scienze Mediche e Sanità Pubblica Università degli Studi di Cagliari

🇮🇹

Cagliari, Sardegna, Italy

A.O.U. "Policlinico-V. Emanuele"- P.O. Ferrarotto

🇮🇹

Catania, Sicilia, Italy

AOU di Padova

🇮🇹

Padova, Veneto, Italy

Azienda Ospedaliero-Universitaria di Parma

🇮🇹

Parma, Emilia-Romagna, Italy

A.O.U. Città della Salute e della Scienza - Presidio Molinette

🇮🇹

Torino, Piemonte, Italy

A.O.U. Integrata Verona - Borgo Roma

🇮🇹

Verona, Veneto, Italy

© Copyright 2025. All Rights Reserved by MedPath